1. Home
  2. BBIO vs WMG Comparison

BBIO vs WMG Comparison

Compare BBIO & WMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • WMG
  • Stock Information
  • Founded
  • BBIO 2015
  • WMG 1929
  • Country
  • BBIO United States
  • WMG United States
  • Employees
  • BBIO N/A
  • WMG N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • WMG Services-Misc. Amusement & Recreation
  • Sector
  • BBIO Health Care
  • WMG Consumer Discretionary
  • Exchange
  • BBIO Nasdaq
  • WMG Nasdaq
  • Market Cap
  • BBIO 12.5B
  • WMG 14.8B
  • IPO Year
  • BBIO 2019
  • WMG 2020
  • Fundamental
  • Price
  • BBIO $71.90
  • WMG $28.16
  • Analyst Decision
  • BBIO Strong Buy
  • WMG Buy
  • Analyst Count
  • BBIO 19
  • WMG 14
  • Target Price
  • BBIO $74.79
  • WMG $35.71
  • AVG Volume (30 Days)
  • BBIO 2.4M
  • WMG 2.1M
  • Earning Date
  • BBIO 10-29-2025
  • WMG 11-20-2025
  • Dividend Yield
  • BBIO N/A
  • WMG 2.71%
  • EPS Growth
  • BBIO N/A
  • WMG N/A
  • EPS
  • BBIO N/A
  • WMG 0.69
  • Revenue
  • BBIO $353,780,000.00
  • WMG $6,707,000,000.00
  • Revenue This Year
  • BBIO $123.32
  • WMG $3.88
  • Revenue Next Year
  • BBIO $73.46
  • WMG $5.74
  • P/E Ratio
  • BBIO N/A
  • WMG $40.39
  • Revenue Growth
  • BBIO 62.46
  • WMG 4.37
  • 52 Week Low
  • BBIO $25.34
  • WMG $25.56
  • 52 Week High
  • BBIO $72.26
  • WMG $36.64
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 71.58
  • WMG 32.37
  • Support Level
  • BBIO $64.41
  • WMG $28.00
  • Resistance Level
  • BBIO $67.71
  • WMG $31.27
  • Average True Range (ATR)
  • BBIO 2.80
  • WMG 0.99
  • MACD
  • BBIO 0.35
  • WMG -0.14
  • Stochastic Oscillator
  • BBIO 95.73
  • WMG 5.96

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About WMG Warner Music Group Corp.

Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappell controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.

Share on Social Networks: